A detailed history of Prestige Wealth Management Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 645 shares of ABBV stock, worth $107,876. This represents 0.03% of its overall portfolio holdings.

Number of Shares
645
Previous 913 29.35%
Holding current value
$107,876
Previous $141,000 17.02%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$159.82 - $182.1 $42,831 - $48,802
-268 Reduced 29.35%
645 $117,000
Q4 2023

Apr 26, 2024

SELL
$137.6 - $154.97 $11,558 - $13,017
-84 Reduced 8.43%
913 $141,000
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $11,558 - $13,017
-84 Reduced 8.43%
913 $141,000
Q3 2023

Apr 26, 2024

SELL
$133.59 - $154.65 $5,610 - $6,495
-42 Reduced 4.04%
997 $148,000
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $5,610 - $6,495
-42 Reduced 4.04%
997 $148,000
Q2 2023

Apr 26, 2024

SELL
$132.51 - $164.9 $655,924 - $816,255
-4,950 Reduced 82.65%
1,039 $139,000
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $655,924 - $816,255
-4,950 Reduced 82.65%
1,039 $139,000
Q1 2023

Apr 26, 2024

BUY
$144.61 - $166.54 $772,795 - $889,989
5,344 Added 828.53%
5,989 $954,000
Q1 2023

May 16, 2023

BUY
$144.61 - $166.54 $693,838 - $799,058
4,798 Added 402.85%
5,989 $954,000
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $582,423 - $698,478
-4,211 Reduced 77.95%
1,191 $192,000
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $66,299 - $76,041
494 Added 10.07%
5,402 $725,000
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $31,377 - $39,890
228 Added 4.87%
4,908 $751,000
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $460,214 - $570,996
3,487 Added 292.29%
4,680 $759,000
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $1,718 - $2,174
16 Added 1.36%
1,193 $161,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $66,925 - $75,970
629 Added 114.78%
1,177 $127,000
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $613 - $675
6 Added 1.11%
548 $60,000
Q4 2020

Feb 17, 2021

BUY
$80.49 - $108.67 $14,568 - $19,669
181 Added 50.14%
542 $58,000
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $103,525 - $138,531
-1,411 Reduced 79.63%
361 $36,000
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $12,642 - $19,166
196 Added 12.44%
1,772 $135,000
Q4 2019

Jan 28, 2020

BUY
$72.13 - $90.25 $8,944 - $11,191
124 Added 8.54%
1,576 $140,000
Q2 2019

Aug 16, 2019

BUY
$65.7 - $83.98 $1,116 - $1,427
17 Added 1.18%
1,452 $105,000
Q1 2019

Aug 16, 2019

BUY
$77.14 - $90.79 $73,283 - $86,250
950 Added 195.88%
1,435 $115,000
Q4 2018

Apr 16, 2019

BUY
$77.85 - $96.01 $37,757 - $46,564
485 New
485 $45,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.